AGENT DE TRAITEMENT DE FIBROSE PULMONAIRE, AGENT FAVORISANT L'EXPRESSION DE PTPRR, ET KIT POUR TRAITEMENT DE FIBROSE PULMONAIRE
- 专利权人:
- Public University Corporation Nara Medical University;Rohto Pharmaceutical Co., Ltd.
- 发明人:
- 申请号：
- EP18753797.2
- 公开号：
- EP3583945A1
- 申请日:
- 2018.02.09
- 申请国别(地区):
- EP
- 年份:
- 2019
- 代理人:
- 摘要：
- The purpose of the present invention is to provide a novel treatment agent for pulmonary fibrosis for which there is currently no effective drug therapy established. The present invention is a therapeutic agent for pulmonary fibrosis containing mesenchymal stem cells. The pulmonary fibrosis is preferably usual interstitial pneumonia (UIP) or idiopathic pulmonary fibrosis (IPF). Also, the mesenchymal stem cells are preferably derived from adipose tissue or are allogeneic.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- THERAPEUTIC AGENT FOR PULMONARY FIBROSIS, PTPRR EXPRESSION-PROMOTOR, AND KIT FOR TREATMENT OF PULMONARY FIBROSIS
- Pulmonary fibrosis therapeutic agent, PTPRR expression promoter and pulmonary fibrosis therapeutic kit
- Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
- PLURIPOTENT STEM CELLS AND METHOD OF STIMULATING AND EXTRACTING NON-EMBRYONIC PLURIPOTENT STEM CELLS FROM MAMMAL BLOOD AND USING RECONSTITUTED PLURIPOTENT STEM CELLS TO TREAT DISEASES INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- PLURIPOTENT STEM CELLS AND METHOD OF STIMULATING AND EXTRACTING NON-EMBRYONIC PLURIPOTENT STEM CELLS FROM MAMMAL BLOOD AND USING RECONSTITUTED PLURIPOTENT STEM CELLS TO TREAT DISEASES INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
